Skip to content

Examination of the effect of Cocoa powder on acute non-inflammatory diarrhea in children 1to 6 years old

Title : Examination of the effect of Cocoa powder on acute non-inflammatory diarrhea in children 1to 6 years old: double- blind randomized clinical trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20230926059525N1
Enrollment
140
Registered
2024-04-04
Start date
2024-04-08
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diarrhea, unspecified. Diarrhea, unspecified

Interventions

Intervention 1: Intervention group: Patients are treated for acute diarrhea according to existing guidelines, and receive 10 mg of zinc syrup daily from Razak Pharmaceutical Company, and children und

Sponsors

Shahre-kord University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 6 Years

Inclusion criteria

Inclusion criteria: Age range from 1 to 6 years Having acute diarrhea according to the clinical history and diagnosis of a pediatric specialist Parental consent to participate in the study The duration of the onset of diarrhea is less than 2 weeks

Exclusion criteria

Exclusion criteria: food allergies and drug allergies associated underlying disease have inflammatory bowel diseases have a bacterial diarrhea

Design outcomes

Primary

MeasureTime frame
Frequency of defecation. Timepoint: Every 24 hours. Method of measurement: The number of defecation in 24 hours is recorded in the checklist.;Stool consistency. Timepoint: Every 24 hours. Method of measurement: The firmness and shape of stool is recorded in the checklist within 24 hours.;Recovery state. Timepoint: Every 24 hours. Method of measurement: The recovery status of the patient is checked according to the symptoms of acute diarrhea.;Disease outcome. Timepoint: Every 24 hours. Method of measurement: At the end of the treatment period, the patient is evaluated in terms of health status according to the data checklist.;Duration of the beginning of treatment to recovery. Timepoint: Every 24 hours. Method of measurement: The time interval (number of days) from the beginning of the treatment regimen until the complete resolution of acute diarrhea symptoms is measured.;Duration of hospitalization. Timepoint: Every 24 hours. Method of measurement: The duration of admission to discharge (number of days) is measured.;Body temperature. Timepoint: Every 24 hours. Method of measurement: The patient's body temperature is measured by the armpit thermometer.;Dehydration. Timepoint: Every 24 hours. Method of measurement: Dehydration symptoms are checked using skin turgor test.;Nausea. Timepoint: Every 24 hours. Method of measurement: The presence or absence of nausea is checked every 24 hours according to the checklist.;Vomiting. Timepoint: Every 24 hours. Method of measurement: The presence or absence of vomiting is checked every 24 hours according to the checklist.;Number of vomiting. Timepoint: Every 24 hours. Method of measurement: The frequency of vomiting per 24 hours is checked according to the checklist.;Age. Timepoint: First day of hospitalization. Method of measurement: The patient's age is calculated in months.;Sex. Timepoint: First day of hospitalization. Method of measurement: Gender of girl/boy is determined by observation.;Weight at the time of admission. Ti

Countries

Iran (Islamic Republic of)

Contacts

Public ContactYegane sadat Miri khorasgani

Shahre-kord University of Medical Sciences

st-miri@skums.ac.ir+98 38 3222 5505

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026